Compile Data Set for Download or QSAR
Report error Found 209 Enz. Inhib. hit(s) with all data for entry = 9170
TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446678BDBM446678(US10669289, Compound 85)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446679BDBM446679(US10669289, Compound 86)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446612BDBM446612(US10669289, Compound 19)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446613BDBM446613(US10669289, Compound 20)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446610BDBM446610(US10669289, Compound 17)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446674BDBM446674(US10669289, Compound 81)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446675BDBM446675(US10669289, Compound 82)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446608BDBM446608(US10669289, Compound 15)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446609BDBM446609(US10669289, Compound 16)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446622BDBM446622(US10669289, Compound 29)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446687BDBM446687(US10669289, Compound 94)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446685BDBM446685(US10669289, Compound 92)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446619BDBM446619(US10669289, Compound 26)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446683BDBM446683(US10669289, Compound 90)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446616BDBM446616(US10669289, Compound 23)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446680BDBM446680(US10669289, Compound 87)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446681BDBM446681(US10669289, Compound 88)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446694BDBM446694(US10669289, Compound 101)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446695BDBM446695(US10669289, Compound 102)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446692BDBM446692(US10669289, Compound 99)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446629BDBM446629(US10669289, Compound 36)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446693BDBM446693(US10669289, Compound 100)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446626BDBM446626(US10669289, Compound 33)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446690BDBM446690(US10669289, Compound 97)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446691BDBM446691(US10669289, Compound 98)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446624BDBM446624(US10669289, Compound 31)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446688BDBM446688([(1R)-1-[[2-(3,5-dichloro-N-prop-2-enoyl-anilino)a...)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446689BDBM446689(US10669289, Compound 96)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446636BDBM446636(US10669289, Compound 43)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446637BDBM446637(US10669289, Compound 44)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446634BDBM446634(US10669289, Compound 41)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446698BDBM446698(US10669289, Compound 105)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446635BDBM446635(US10669289, Compound 42)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446696BDBM446696(US10669289, Compound 103)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446697BDBM446697(US10669289, Compound 104)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446643BDBM446643(US10669289, Compound 50)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446654BDBM446654(US10669289, Compound 61)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446652BDBM446652(US10669289, Compound 59)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446653BDBM446653(US10669289, Compound 60)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446648BDBM446648(US10669289, Compound 55)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446649BDBM446649(US10669289, Compound 56)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446663BDBM446663(US10669289, Compound 70)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446660BDBM446660(US10669289, Compound 67)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446597BDBM446597(US10669289, Compound 4)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446658BDBM446658(US10669289, Compound 65)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446594BDBM446594(US10669289, Compound 1)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446659BDBM446659(US10669289, Compound 66)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446595BDBM446595(US10669289, Compound 2)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446656BDBM446656(US10669289, Compound 63)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

TargetProteasome subunit beta type-8(Human)
Merck Patent

US Patent
LigandChemical structure of BindingDB Monomer ID 446606BDBM446606(US10669289, Compound 13)
Affinity DataIC50: 50nMAssay Description:Measurement of LMP7 inhibition is performed in 384 well format based on fluorescence intensity assay.Purified human immuno proteasome (0.25 nM) and s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details
US Patent

Displayed 1 to 50 (of 209 total ) | Next | Last >>
Jump to: